Jeppe Øvli Øvlesen
CEO, board memberHe has previously worked as CEO for ChemoMetec (listed), Pnn Medical and as CFO & VP Business development for Action Pharma. (sold to AbbVie).
A cofounder/founding board member Cetrea (sold to Marque), CLC Bio (sold to Quagen), Monsenso, Enovacor, Biostrip, VikarBasen, Perfusion Tech, Synact Pharma (listed) and TXP Pharma.